India Leadership Conclave

Padma Shri Dr Mukesh Batra, Founder Chairman Emeritus,Dr Batra's® Healthcare addressing on Reviving Hahnemann: A Modern Reappraisal of the Founder of Homeopathy and His Medical Philosophy at the 16th Annual Healthcare Leadership Summit & Awards 2024 on Friday 20th December at Hotel Hilton Mumbai International Airport  #DrMukeshBatra

The global healthcare industry is a multi-trillion-dollar enterprise. In recent years, it has experienced exponential growth, driven by factors such as aging populations, increasing prevalence of chronic diseases, and technological advancements. The pharmaceutical industry, a key component of this sector, is a major contributor to global GDP. The development and commercialization of innovative drugs and vaccines generate substantial revenue. Big debate at 16th Annual Healthcare Super Brand Summit & Awards.

pharmaleaders is set to host the 16th Annual Healthcare Leadership Summit under the theme "Trailblazing the Future: Leaders and Innovations Shaping Modern Healthcare." This summit serves as a vital platform to spotlight challenges, share insights, and propose innovative solutions to redefine the future of healthcare in India. Dr Satya Brahma strongly feels that despite all success, India's healthcare system is at a crossroads, grappling with severe systemic issues that cannot be overlooked: • Absence of Universal Health Insurance: A significant portion of our population remains without access to essential healthcare coverage, leaving many vulnerable to medical and financial crises. • Limited Access to Medicines: The affordability and availability of life-saving drugs are still major concerns, especially in rural and underserved areas. • Critical Doctor-Patient Ratio: The shortage of healthcare professionals continues to compromise the quality of care, particularly in remote regions. These persistent challenges underscore the need for immediate, focused, and sustained action. To build a healthier and more equitable India, we call on the government and stakeholders to take decisive measures: 1. Increase Healthcare Spending: Raise the healthcare budget as a proportion of GDP to strengthen infrastructure, workforce, and service delivery mechanisms. 2. Enhance Ayushman Bharat Implementation: Establish robust monitoring and evaluation systems to ensure that the scheme reaches the underserved and fulfills its potential as a transformative healthcare initiative. 3. Promote Equitable Healthcare Access: Design and implement policies aimed at achieving universal health coverage and ensuring affordability, quality, and accessibility for all citizens. This summit is a rallying cry for policymakers, healthcare leaders, innovators, and the broader community to join forces in addressing these critical gaps. Together, we can transform India's healthcare landscape and secure a healthier future for generations to come. We invite all stakeholders to contribute their voices, share their expertise, and collaborate toward a shared vision of progress and inclusivity in healthcare. #HealthcareInnovation #pharmaleaders2024 #healthcareleadershipsummit #PatientFirst #PatientCare

pharmaleaders, the healthcare market research and communication firm of the Illustrious Network 7 Media Group, is delighted to announce that Mr. Anil Matai, Director General of The Organisation of Pharmaceutical Producers of India OPPI India will be presenting a special address on: “Affordable Healthcare for All: The Crucial Role of Government Support and Progressive Reforms” .Mr. Matai is a seasoned general management professional with extensive experience in the Healthcare, Pharmaceutical, and Life Sciences sectors. His illustrious career spans leadership roles at globally renowned organizations such as Novartis India Ltd., GSK India, Globalpharma in Dubai, and Zydus Healthcare Ltd., where he served as Managing Director before his retirement. Following his tenure at Zydus, Mr. Matai contributed as Senior Advisor – Life Sciences at IQVIA Consulting and Information Services India Pvt. Ltd. and most recently as Operating Partner at Jashvik Capital, a mid-market Private Equity Fund focused on Healthcare and Consumer sectors. With a proven track record of driving growth, operational excellence, and transformative strategies, Mr. Matai has Spearheaded multi-million-dollar businesses. Delivered market-leading results by executing robust growth strategies and enhancing productivity.Successfully improved market share and EBIDTA margins by over 40% at Zydus Healthcare Ltd.Oversaw Novartis India’s pharmaceutical business growth, surpassing the MNC pharma sector. His strategic expertise is complemented by his participation in Senior Executive Programs at Harvard Business School, USA, and IMD Business School, Switzerland. A Visionary Leader, Mr. Matai’s insights into operational ingenuity, team building, deal negotiations, regulatory compliance, and market dynamics have positioned him as a thought leader in the industry. He has also served on the boards of several leading pharmaceutical companies, including Zydus Healthcare Ltd., Bayer Zydus Pharma Private Ltd., Novartis Healthcare Private Ltd., and Biochem Pharmaceutical Industries Ltd. We are honored to host Mr. Matai’s address, which promises to provide invaluable insights into the intersection of policy, innovation, and healthcare accessibility. #Dec20thWithSatyaBrahma #PharmaLeaders2024 #HealthcareSuperBrandAwards #Healthcare

pharmaleaders Leaders, the global healthcare communication market research arm of Network 7 Media Group, is delighted to announce the participation of the visionary technocrat, Dr.Satya Ramani Vadlamani 👩🔧, Chairperson and Managing Director of Murli Krishna Pharma Pvt. Ltd. at the 16th Annual Edition of Healthcare Super Brands. Dr. Satya Vadlamani has carved an unparalleled niche in the pharmaceutical industry. Beginning her illustrious journey in 2004 with the manufacturing of semi-finished formulations, Dr. Satya emerged as a pioneer in Contract Research and Manufacturing Services (CRAMS). Her groundbreaking contributions have set new benchmarks in pharmaceutical manufacturing and research, redefining the CRAMS landscape. 🏛️💡 An Electrical and Electronics Engineer by education 🔧, Dr. Satya brings more than 22 years of experience in global marketing of pharmaceutical products 📝🌍. Her transformative leadership has not only propelled Murli Krishna Pharma Pvt. Ltd. to global prominence but has also touched countless lives through her passion, determination, and innovative spirit. 🌟 A beacon of women empowerment 🌸, Dr. Satya continues to inspire and uplift others with her remarkable achievements and relentless pursuit of excellence. 💪✨ Dr. Satya Vadlamani will address the forum on the topic: "Revolutionizing CRAMS: The New Frontier in Pharmaceutical Manufacturing and Research." 🔬⚖️ Stay tuned as Pharma Leaders celebrates this extraordinary leader who embodies innovation, resilience, and visionary leadership in the healthcare industry. 🎉🎨 #PharmaLeaders #HealthcareSuperBrands #DrSatyaVadlamani #CRAMSInnovation #WomenEmpowerment #PharmaExcellence #VisionaryLeadership

Meet The Legend Dr. V. Mohan Diabetes Specialist 🎉 Pharma Leaders, the global healthcare market research arm of Network 7 Media Group, takes immense pride in presenting Padma Shri Dr. V. Mohan, a luminary in the field of diabetes care and research, as a featured speaker. Padma Shri Dr. Mohan is an internationally acclaimed diabetologist and scientist with an illustrious career spanning over 40 years. As the Chairman and Chief of Diabetology at Dr.Mohan's Diabetes Specialities Centre , a globally recognized IDF Centre of Education and Centre of Excellence in Diabetes Care, his contributions have redefined the landscape of diabetes management and education. A true visionary, Dr. Mohan is the driving force behind a pioneering chain of 50 diabetes care centers across India. With an unrelenting focus on combating diabetes, his leadership at the Madras Diabetes Research Foundation has yielded groundbreaking insights into the unique challenges faced by South Asians, especially the prevalence of insulin deficiency over insulin resistance. Dr. Mohan’s efforts resonate deeply in a nation grappling with alarming statistics—101 million people living with diabetes and 136 million individuals with prediabetes. His tireless work underscores the urgent need for education, healthcare innovation, and sustained action to address this public health crisis. Join us in celebrating the extraordinary achievements of Padma Shri Dr. V. Mohan and his unwavering commitment to transforming diabetes care in India and beyond! 🌟 #HealthcareSuperBrands #DrVMohan #PharmaLeaders2024

India’s Premier Healthcare Leaders and Business Reformers to Debate at the 16th Annual Pharma Leaders Summit, Hosted by the Global Healthcare Media & Market Consulting Group Network 7 Media Group The 16th Annual Pharma Leaders Summit, a hallmark event in the healthcare industry, will host a ground-breaking debate featuring India's most esteemed healthcare leaders and business reformers. Organized by the Global Healthcare Media & Market Consulting Group, this summit is set to bring together the brightest minds and influential figures in the healthcare sector. Attendees can expect a series of thought-provoking discussions and debates on the most pressing issues facing the healthcare industry today. Topics will range from the latest advancements in medical technology and pharmaceutical innovations to the challenges of regulatory compliance and healthcare accessibility. The summit will provide a unique platform for leaders to exchange ideas, share their visionary insights, and explore collaborative opportunities to drive the future of healthcare. This year's theme underscores the urgent need for progressive reforms and government support to ensure affordable healthcare for all. Participants will benefit from the collective wisdom of experts who have shaped the landscape of Indian healthcare and beyond. The event promises to foster an environment of learning, inspiration, and strategic dialogue, contributing to the continued growth and improvement of healthcare services in India. Stay tuned for more details as we approach this momentous event, where the future of healthcare will be debated and shaped by the most respected and influential voices in the industry. #20ThDecemberWithSatyaBrahma

The dialysis market in India is projected to grow significantly, with a compound annual growth rate (CAGR) of around 9.60% from 2024 to 2032. This growth is driven by the increasing prevalence of chronic kidney disease (CKD) and rising awareness about dialysis treatment.Government Initiatives: Programs like the Pradhan Mantri National Dialysis Programme (PMNDP) aim to make dialysis services more accessible and affordable, especially in rural and underserved areas. Companies are adopting advanced technologies to improve the quality and efficiency of dialysis treatment. Innovations in dialysis technology, such as more efficient hemodialysis machines and peritoneal dialysis solutions, are helping to enhance patient outcomes and comfort.Companies offer a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services. Here are the six finalists for the coveted award category of "India’s Most Trusted & Valuable & Technology driven Patient-Centric Dialysis Centre" 1.     DCDC Kidney Care Aseem Garg Akshat Garg Sunny Chopra 2.     Apex Kidney Care Pvt Ltd Indranil Roy Choudhury Prakash Shyam Shirodkar 3.     Fresenius Medical Care Bhaskar Guha Punit Kohli 4.     NephroPlus Vikram Vuppala Prashant Goenka Rohit Singh 5.     The Renal Project Shashank Moddhia CMQ OE Ananthaprakash Thiyagarajan Jitesh Pednekar 6.     SAP MEDICALS PRIVATE LIMITED Mohammed Niaz Ahmed Khan #PharmaLeaders2024 #HealthcareSuperBrands #PatientCentricDialysisCentre  To Vote : https://lnkd.in/gT-UKmFB https://lnkd.in/grDxXena

The Pharmaceutical Contract Research and Manufacturing Services (CRAMS) market in India is experiencing significant growth. As of 2024, the market size is valued at approximately $44 billion and is expected to continue expanding due to increased demand for cost-effective and high-quality pharmaceutical solutions. Indian companies are at the forefront of this industry, leveraging innovations in technology and process improvements to provide competitive services globally. Pharma Leaders, the global healthcare leadership brand, is hosting its flagship annual healthcare event, now in its 16th year. This prestigious event will select the leader in the coveted category of "India’s Most Trusted & Valuable Pharmaceutical Company in CRAMS". The award recognizes companies that have demonstrated manufacturing excellence in the Contract Research and Manufacturing Services (CRAMS) market. The award ceremony will take place on the 16th of December, 2024, where the winner of this esteemed category will be announced. This recognition highlights the pivotal role of CRAMS in the pharmaceutical industry and celebrates the exceptional contributions of leaders who drive innovation and uphold the highest standards of quality and reliability in manufacturing processes. India’s Most Trusted & Valuable Pharmaceutical Company in CRAMS Nominees 1. Dishman Carbogen Amcis Ltd Janmejay Vyas Harshil Dalal 2. Zeon Lifesciences Ltd Suresh Garg Dr.Vivek Srivastav  3. Tirupati Group TIRUPATI GROUP Ajay Goel Deepak Goyal 4. Symbio Generrics India Pvt. Ltd. Akash Puranik Salim Shaikh Sadiq 5. Prakruti life science Srinath Shetty Nikhil Hegde  6. SAIN MEDICAMENTS PVT. LTD SUMIT AGARWAL Manmeet Agarwal #PharmaLeaders2024 #HealthcareSuperBrands #LeaderInCrams To Vote : https://lnkd.in/gGtmPwYT https://lnkd.in/grDxXena

The prestigious award for the category of "India’s Most Valuable Pharma API Company Of The Year 2024" will be awarded to a company that has demonstrated exceptional leadership in the Pharma API market. The Pharma API market in India, which is valued at approximately $10.9 billion in 2024, plays a crucial role in the global pharmaceutical supply chain. This accolade recognizes outstanding contributions and innovations that have significantly advanced the industry. India’s Most Valuable Pharma API Company Of The Year Nominees NAKODA CHEMICALS LIMITED RAJKUMAR AGRAWAL Chandra sekhar Aarey Drugs & Pharmaceuticals Limited Nimit Ghatalia Nuray Chemicals Pvt. Ltd.. Dr. G. Panchapakeaan Ganapathy Ravi Kulandasamy Proventus Life Sciences Pvt Ltd Ayush Sultania Swati Bhaiya dilip shah Morepen Laboratories Limited India Sushil Suri ASHUTOSH SHARMA Blue Jet Healthcare Ltd Akshay Arora Sweta Poddar #PharmaLeaders2024 #HealthcareSuperBrands #PharmaLeadersAPILeader To Vote : https://lnkd.in/gyyCHuWN https://lnkd.in/grDxXena